Free Trial

Radiopharm Theranostics (RADX) Earnings Date, Estimates & Call Transcripts

Radiopharm Theranostics logo
$4.25 -0.34 (-7.41%)
Closing price 04:00 PM Eastern
Extended Trading
$4.42 +0.17 (+3.95%)
As of 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Radiopharm Theranostics Earnings Summary

Radiopharm Theranostics announced Q2 2026 earnings on January 28, 2026, reporting an EPS of -$1.58. Quarterly revenue was reported to be $0.46 million. With a trailing EPS of $0.00, Radiopharm Theranostics' earnings are expected to grow next year, from ($1.80) to ($1.22) per share.

Q2 2026 Earnings Resources

Actual Revenue
(Jan. 28)
$0.46M
Get Radiopharm Theranostics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Radiopharm Theranostics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Radiopharm Theranostics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.80) EPS
Next Year EPS Consensus Estimate
($1.22) EPS

Radiopharm Theranostics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
1/28/2026Q2 2026--$1.5750--$1.5750-$0.46M

Data powered by Fiscal.ai.

Radiopharm Theranostics Earnings - Frequently Asked Questions

Radiopharm Theranostics (NASDAQ:RADX) last announced its quarterly earning data on Wednesday, January 28, 2026. Learn more on RADX's earnings history.

Radiopharm Theranostics (NASDAQ:RADX) has a recorded annual revenue of $2.35 million.

Radiopharm Theranostics (NASDAQ:RADX) has a recorded net income of -$24.83 million. RADX has generated $0.00 earnings per share over the last four quarters.

Radiopharm Theranostics' earnings are expected to grow from ($1.80) per share to ($1.22) per share in the next year.


This page (NASDAQ:RADX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners